Home

Dentar Frumos tabla de scris programme teva 19 aout 2018 luptă Izola Întradevăr

Pharmaceuticals | Free Full-Text | Cannabis-Based Medicine for Neuropathic  Pain and Spasticity—A Multicenter, Randomized, Double-Blinded,  Placebo-Controlled Trial
Pharmaceuticals | Free Full-Text | Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

EX-99.2
EX-99.2

iPS-cell-derived microglia promote brain organoid maturation via  cholesterol transfer | Nature
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer | Nature

Needle-Free Delivery Technology Market 2018-2028 - Visiongain
Needle-Free Delivery Technology Market 2018-2028 - Visiongain

Teva Pharm gets approval in China for Huntington's treatment | Reuters
Teva Pharm gets approval in China for Huntington's treatment | Reuters

Proxy-analysis of the genetics of cognitive decline in Parkinson's disease  through polygenic scores | npj Parkinson's Disease
Proxy-analysis of the genetics of cognitive decline in Parkinson's disease through polygenic scores | npj Parkinson's Disease

JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the  Epidemiological Situation of Pulmonary Tuberculosis–Using Natural  Language Processing
JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis–Using Natural Language Processing

Latino Leaders May - June by Latino Leaders - Issuu
Latino Leaders May - June by Latino Leaders - Issuu

Safety and efficacy of elsubrutinib or upadacitinib alone or in combination  (ABBV-599) in patients with rheumatoid arthritis and inadequate response or  intolerance to biological therapies: a multicentre, double-blind,  randomised, controlled, phase 2
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2

Pipeline - Tarsier® Pharma
Pipeline - Tarsier® Pharma

World Health Organization cardiovascular disease risk charts: revised  models to estimate risk in 21 global regions - The Lancet Global Health
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions - The Lancet Global Health

Teva secures FDA approval for Ajovy to prevent migraine episodes
Teva secures FDA approval for Ajovy to prevent migraine episodes

Genome-wide Association and Meta-analysis of Age at Onset in Parkinson  Disease | Neurology
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease | Neurology

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes |  Neurology Neuroimmunology & Neuroinflammation
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes | Neurology Neuroimmunology & Neuroinflammation

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease  | npj Parkinson's Disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease | npj Parkinson's Disease

Antibiotics | Free Full-Text | Vaccination against Community-Acquired  Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts  Prevention Group
Antibiotics | Free Full-Text | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group

IJERPH | Free Full-Text | Protocol for the Implementation and Assessment of  “MoodUP”: A Stepped Care Model Assisted by a Digital Platform to Accelerate  Access to Mental Health Care for Cancer Patients
IJERPH | Free Full-Text | Protocol for the Implementation and Assessment of “MoodUP”: A Stepped Care Model Assisted by a Digital Platform to Accelerate Access to Mental Health Care for Cancer Patients

IJERPH | Free Full-Text | Consolidation, Stages of Change, and Loyalty  among Users of Public Sports and Health Services Aged 12–16
IJERPH | Free Full-Text | Consolidation, Stages of Change, and Loyalty among Users of Public Sports and Health Services Aged 12–16

Global burden of 87 risk factors in 204 countries and territories,  1990–2019: a systematic analysis for the Global Burden of Disease Study  2019 - The Lancet
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet

Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion  imaging: a systematic review and meta-analysis of individual patient data -  The Lancet
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data - The Lancet

Patient-specific models link neurotransmitter receptor mechanisms with  motor and visuospatial axes of Parkinson's disease | Nature Communications
Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson's disease | Nature Communications

PharmaBoardroom - TEVA, Portugal
PharmaBoardroom - TEVA, Portugal

Measuring universal health coverage based on an index of effective coverage  of health services in 204 countries and territories, 1990–2019: a  systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet